Founded in 2013 and based in San Diego, California, Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) is a commercial mRNA medicines and vaccines company with enabling technologies: (i) LUNAR® lipid-mediated delivery, (ii) STARR® mRNA technology (sa-mRNA) and (iii) mRNA drug substance along with drug product manufacturing expertise. Arcturus developed KOSTAIVE®, the first self-amplifying messenger RNA (sa-mRNA) COVID vaccine in the world to be approved. Arcturus has an ongoing global collaboration for innovative mRNA vaccines with CSL Seqirus, and a joint venture in Japan, ARCALIS, focused on the manufacture of mRNA vaccines and therapeutics. Arcturus’ pipeline includes RNA therapeutic candidates to potentially treat OTC deficiency and cystic fibrosis (CF), along with its partnered mRNA vaccine programs for SARS-CoV-2 (COVID-19) and influenza. Arcturus’ versatile RNA therapeutics platforms can be applied toward multiple types of nucleic acid medicines including messenger RNA, small interfering RNA, circular RNA, antisense RNA, self-amplifying RNA, DNA, and gene editing therapeutics. Arcturus' technologies are covered by its extensive patent portfolio (over 500 patents and patent applications in the U.S., Europe, Japan, China, and other countries).
Company Details
- Employees
- 184
- Founded
- -
- Address
- 10628 Science Center Drive,
- Phone
- 858-900-2660
- in****@****sRx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- arcturusrx.com
- Keywords
- mRNA, Lipid-Mediated Delivery, Rare Diseases, OTC Deficiency, Cystic Fibrosis, Vaccines, Therapeutics, HBV, Coronavirus, COVID-19, Lipids, LUNAR, STARR, Innovation, Discovery, Leadership, Partnerships, RNA, Development, mRNA medicine, Glycogen Storage disease.
- HQ
- San Diego, CA
Arcturus Therapeutics Questions
Arcturus Therapeutics's helpline number is 858-900-2660
Arcturus Therapeutics's website is arcturusrx.com
Arcturus Therapeutics's LinkedIn profile is https://www.linkedin.com/company/arcturus-therapeutics
Arcturus Therapeutics has
184 employees.
View email and phone details for 184
employees at Arcturus Therapeutics.
Arcturus Therapeutics's industry is
Biotechnology Research
Arcturus Therapeutics's top competitors are
Seawolf Therapeutics, Inc.,
Neurocrine Biosciences,
Csl,
Poseida Therapeutics, Inc.,
Capstan Therapeutics,
Avidity Biosciences, Inc.,
Vertex Pharmaceuticals,
Crinetics Pharmaceuticals,
Fate Therapeutics Inc.,
Ionis Pharmaceuticals, Inc..
Arcturus Therapeutics's support email address is info@ArcturusRx.com
Arcturus Therapeutics's categories are Biotechnology Research
Arcturus Therapeutics's founding year is 2013
